Quantcast

New Haven, Conn. – A team led by Yale University researchers has used nanosensors to measure cancer biomarkers in whole blood for the first time. Their findings, which appear December 13 in the advanced online publication of Nature Nanotechnology, could dramatically simplify the way physicians test for biomarkers of cancer and other diseases.

Leave a Reply

Your email address will not be published. Required fields are marked *

*